Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Lanzhou University has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners and 3 distinct art units, so the portfolio requires coordination across separate technical and examination assignments.
CHICKS, ASHLI ARIANA is the busiest examiner, with 1 pending matter. No single examiner accounts for a larger recorded share, making a consistent underlying claim strategy useful while responses address each action on its own terms.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §102 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHICKS, ASHLI ARIANA | 1 | 60.0% | +51.0% |
| HOBAN, MATTHEW E | 1 | 60.4% | +25.6% |
| LEWOCZKO, EVAN MICHAEL | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18866823 | USE OF PHENOLIC ACIDS DERIVATIVES IN TREATING ISCHEMIC STROKE | CHICKS, ASHLI ARIANA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18866823 | USE OF PHENOLIC ACIDS DERIVATIVES IN TREATING ISCHEMIC STROKE | CHICKS, ASHLI ARIANA | — |
| 18801846 | SOFT MAGNETIC COMPOSITE WITH TWO-DIMENSIONAL MAGNETIC MOMENT AND HIGH WORKING FREQUENCY BAND, AND PREPARATION METHOD THEREFOR | HOBAN, MATTHEW E | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| 1734 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18866823 | USE OF PHENOLIC ACIDS DERIVATIVES IN TREATING ISCHEMIC STROKE | CHICKS, ASHLI ARIANA | 1626 | §103§112 | Non-Final OA | — | Pending | Nov 18, 2024 |
| 18801846 | SOFT MAGNETIC COMPOSITE WITH TWO-DIMENSIONAL MAGNETIC MOMENT AND HIGH WORKING FREQUENCY BAND, AND PREPARATION METHOD THEREFOR | HOBAN, MATTHEW E | 1734 | §102 | Final Rejection | — | Pending | Aug 13, 2024 |
| 18465807 | MULTI-MODALITY MOLECULAR IMAGING PROBE, AND PREPARATION METHOD AND USE THEREOF | LEWOCZKO, EVAN MICHAEL | 1612 | §103 | Final Rejection | — | Pending | Sep 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLanzhou University has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Ashli Ariana Chicks has the most, with 1 of Lanzhou University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
